Drugs / MVA-HBVac
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06513286 | Jun 2025 → Dec 2026 expected | chronic hepatitis B virus infection | Michael Hoelscher | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MVA-HBVac | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06513286 ↗ |